LifeStance Health Group, Inc. - Form 8-K Summary
Business Context and Reporting Period
LifeStance Health Group, Inc. (LFST) filed a Current Report on Form 8-K on May 7, 2026. The filing announces the results of operations for the first quarter ended March 31, 2026. The company is incorporated in Delaware and operates on The Nasdaq Global Select Market.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) and a slide presentation (Exhibit 99.2) containing the actual financial data. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics for the period.
Material Changes
The filing text does not contain specific data regarding material changes versus the prior comparable period. Investors must refer to the referenced press release for comparative analysis.
Guidance, Outlook, and Risks
The filing includes a slide presentation with supplemental information under Item 7.01 Regulation FD Disclosure. However, the text of the 8-K itself does not detail specific guidance, management commentary, risks, contingencies, or unusual items. The information in the exhibits is not deemed "filed" for purposes of Section 18 of the Exchange Act unless expressly incorporated by reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2026 revenue, net income, and EBITDA figures.
- Examine Exhibit 99.2 (Slide Presentation) for forward-looking guidance and operational metrics.
- Verify the company's liquidity position and debt covenants in the full press release, as these are not listed in the 8-K text.
- Confirm any updates to risk factors or contingencies mentioned in the supplemental materials.